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Background: The objective of this study was to develop and validate a short form of the Patient
HealthQuestionnaire-9 (PHQ-9), a self-report questionnaire for assessing depressive symptoma-
tology, using objective criteria.
Methods: Responses on the PHQ-9 were obtained from 7,850 English-speaking participants
enrolled in 20 primary diagnostic test accuracy studies. PHQunidimensionality was verified using
confirmatory factor analysis, and an item response theory model was fit. Optimal test assembly
(OTA) methods identified a maximally precise short form for each possible length between one
and eight items, including and excluding the ninth item. The final short formwas selected based on
prespecified validity, reliability, and diagnostic accuracy criteria.
Results: A four-item short form of the PHQ (PHQ-Dep-4) was selected. The PHQ-Dep-4 had
a Cronbach's alpha of 0.805. Sensitivity and specificity of the PHQ-Dep-4 were 0.788 and
0.837, respectively, and were statistically equivalent to the PHQ-9 (sensitivity = 0.761, speci-
ficity= 0.866). The correlation of total scores with the full PHQ-9was high (r= 0.919).
Conclusion: The PHQ-Dep-4 is a valid short formwithminimal loss of information of scores when
compared to the full-length PHQ-9. Although OTA methods have been used to shorten patient-
reported outcomemeasures based on objective, prespecified criteria, further studies are required
to validate this general procedure for broader use in health research. Furthermore, due to unex-
amined heterogeneity, there is a need to replicate the results of this study in different patient
populations.
K EYWORDS
depression, Patient Health Questionnaire, patient outcome assessment, psychometrics
1 INTRODUCTION
In mental health research and clinical practice, self-report symp-
tom measures are used to assess patient symptoms and identify
patients with undetected mental disorders. Completing these mea-
sures is demanding, especially when people are asked to respond
to multiple measures that each contain multiple items (Coste,
Guillemin, Pouchot, & Fermanian, 1997; Goetz et al., 2013; Kruyen,
Emons, & Sijtsma, 2013; Stanton, Sinar, Balzer, & Smith, 2002).
Therefore, researchers attempt to create shortened versions with
scores that perform comparably well with original full-length ver-
sions (Coste et al., 1997; Goetz et al., 2013; Kruyen et al., 2013;
Stanton et al., 2002).
The Patient Health Questionnaire-9 (PHQ-9) is a nine-item, self-
report questionnaire that measures depressive symptomatology
(Kroenke & Spitzer, 2002; Kroenke et al., 2009; Kroenke, Spitzer, &
Williams, 2001). A recent meta-analysis of the PHQ-9 found that at
the standard cutoff of 10, based on 34 studies, the sensitivity and
specificity were 0.78 and 0.87, respectively (Moriarty, Gilbody,
McMillan, &Manea, 2015).
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The PHQ-8 is similar to the PHQ-9 and is increasingly used because
it eliminates one item that asks about patients’ thoughts of either self-
harm or being “better off dead” (Kroenke & Spitzer, 2002), but it iden-
tifies large numbers of patients not at risk of suicide (Dube, Kroenke,
Bair, Theobald, &Williams, 2010; Razykov, Hudson, Baron, & Thombs,
2013). Many studies have reported that the PHQ-8 performs nearly
identically to the PHQ-9 (Corson, Gerrity, & Dobscha, 2004; Kroenke
& Spitzer, 2002; Leadbeater, Carruthers, Green, Rosser, & Field, 2011;
Razykov et al., 2013).
The PHQ-2 is another short-form, designed to include the two core
items in aDiagnostic andStatisticalManual ofMentalDisorders (DSM)
Major Depressive Disorder (MDD) diagnosis: depressed mood and
anhedonia (Kroenke, Spitzer,&Williams, 2003).A recentmeta-analysis
of the PHQ-2 found that at a cutoff of 2, based on 17 studies, the sensi-
tivity and specificitywere0.91 and0.70, respectively,whereas at a cut-
off of 3, based on 19 studies, the sensitivity and specificity were 0.76
and 0.87, respectively (Manea et al., 2016).
Conventionally, short forms of patient-reported measures are cre-
ated through an expert-based analysis of item content, as with the
PHQ-2, or by removing items with minimal factor loadings (Goetz
et al., 2013). These methods are not typically applied in a system-
atic way, and multiple shortened versions of the same measure may
exist (Coste et al., 1997; Goetz et al., 2013; Kruyen et al., 2013;
Smith, McCarthy, & Anderson, 2004; Stanton et al., 2002). Meth-
ods such as item response theory (IRT; van der Linden & Hamble-
ton, 2013) have been used to evaluate and identify problematic items,
but have not incorporated objective and reproducible criteria for item
selection.
Optimal test assembly (OTA) is a mixed-integer programming pro-
cedures that uses an estimated IRTmodel to select the subset of items
that best satisfies prespecified constraints (van der Linden, 2006).
Although more commonly used in the development of high-stakes
educational tests (Holling, Kuhn, & Kiefer, 2013), a recent study
demonstrated that OTA can be used to develop shortened versions
of patient-reported outcome measures (A. W. Levis et al., 2016). This
procedure was also shown to be replicable, reproducible, and produce
shortened forms of minimal length as compared with leading alterna-
tive methods (Harel & Baron, 2018).
The objective of the present study was to apply OTA to develop
a shortened version of the PHQ-9. We (a) used confirmatory factor
analysis to verify the unidimensionality of the underlying construct;
(b) applied OTA methods to obtain candidate forms of each possible
length; and (c) selected the shortest possible form that showed simi-
lar performance to the full form in terms of prespecified validity, relia-
bility, and diagnostic accuracy criteria, compared to the PHQ-9 as the
full-form standard.
2 MATERIALS AND METHODS
This study used a subset of data accrued for an individual participant
data meta-analysis (IPDMA) on the diagnostic accuracy of the
PHQ-9 depression screening tool to detect major depres-
sion (in progress). The IPDMA was registered in PROSPERO
(CRD42014010673), and a protocol was published (Thombs et al.,
2014).
2.1 Search strategy
A medical librarian searched Medline, Medline In-Process, and Other
Nonindexed Citations via Ovid, PsycINFO, and Web of Science (Jan-
uary 2000 to December 2014) on February 7, 2015, using a peer-
reviewed search strategy (Supporting Information Methods 1). We
also reviewed reference lists of relevant reviews and queried con-
tributing authors about nonpublished studies. Search results were
uploaded into RefWorks (RefWorks-COS, Bethesda, MD). After de-
duplication, unique citations were uploaded into DistillerSR (Evidence
Partners, Ottawa, Canada), for storing and tracking search results.
2.2 Identification of eligible studies for full IPDMA
Datasets fromarticles in any languagewere eligible for inclusion if they
included diagnostic classifications for current MDD or Major Depres-
sive Episode (MDE) based on a validated semistructured or fully struc-
tured interview conducted within 2 weeks of PHQ-9 administration,
among participants ≥18 years and not recruited from youth or psychi-
atric settings. Datasets where not all participants were eligible were
included if primary data allowed selection of eligible participants. For
defining major depression, we considered MDD or MDE based on the
DSM or MDE based on the International Classification of Diseases
(ICD). If more than one was reported, we prioritized DSM over ICD
and DSMMDE over DSMMDD. Across all studies, there were 23 dis-
cordant diagnoses depending on classification prioritization (0.1% of
participants).
Two investigators independently reviewed titles and abstracts for
eligibility. If either deemed a study potentially eligible, full-text review
was completed by two investigators, independently, with disagree-
ments resolvedby consensus, consulting a third investigatorwhennec-
essary. Translators were consulted to evaluate titles, abstracts, and
full-text articles.
2.3 Data contribution and synthesis
Authors of eligible datasets were invited to contribute de-identified
primary data. We compared published participant characteristics
and diagnostic accuracy results with results from raw datasets
and resolved any discrepancies in consultation with the original
investigators.
2.4 Data selection for present study
We restricted our dataset to participants who completed the PHQ-
9 in English, due to the potential for heterogeneity across studies
conducted in different languages. We excluded studies that classi-
fied major depression using the Mini International Neuropsychiatric
Interview (MINI), because it is structurally different from other fully
structured interviews and classifies approximately twice as many
participants as cases compared to the most commonly used fully
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structured interview, the Composite International Diagnostic Inter-
view (CIDI; B. Levis et al., 2018).
2.5 Measure
Scores on each PHQ-9 item reflect frequency of symptoms in the last
2 weeks and range from 0 (“not at all”) to 3 (“nearly every day”). Higher
scores indicate greater depressive symptomatology. Total scores range
from 0 to 27 (Kroenke et al., 2001).
2.6 Statistical analyses
2.6.1 Verification of unidimensionality of the PHQ-9
Robust weighted least squares estimation in Mplus was used to fit
a single-factor confirmatory factor analysis model of PHQ-9 items
(Muthén &Muthén, 2012). Themodel was first fit without allowing for
any residual correlations among the items. Then modification indices
were used to identify item pairs that would improve model fit if their
residuals were allowed to correlate, if there was theoretical justifica-
tion (McDonald & Ho, 2002). Model fit was evaluated concurrently,
using: the 𝜒2 statistic, comparative fit index (CFI), Tucker–Lewis index
(TLI), and root mean square error of approximation (RMSEA; Chen,
Curran, Bollen, Kirby, & Paxton, 2008). Priority was given to CFI, TLI,
and RMSEA, because the 𝜒2 test may reject well-fitting models when
sample size is large (Reise, Widaman, & Pugh, 1993). Model fit was
considered adequate if CFI and TLI ≥ 0.95 and RMSEA ≤ 0.08 (Hu &
Bentler, 1999).
2.6.2 Item response theorymodel and optimal test
assembly
A generalized partial credit model (GPCM) was fit to PHQ-9 (Muraki,
1992). The GPCM is an IRT model that relates a latent trait, rep-
resenting severity of depressive symptomatology, to the distribution
of observed item-level responses. The GPCM estimates two types of
item-specific parameters: a discrimination parameter and threshold
parameters. From these item-level parameter estimates, item infor-
mation functions for each item were calculated from the GPCM,
as well as a test information function (TIF), obtained by summing
item information functions. Because the TIF is inversely related to
the standard error of measurement of the latent trait, high amounts
of information represent greater precision for measuring depressive
symptomatology.
Next, we usedOTA, amixed-integer programming technique to sys-
tematically search for the short form that maximized the TIF, subject
to the constraint of fixing the number of items included in each short
form, optimizing the precision of the short form in estimating partici-
pants’ level of depressive symptomatology (Boekkooi-Timminga, 1989;
van der Linden, 2006). The shape of the TIFwas anchored at five points
(van der Linden, 2006). Thus, for each short form of lengths one to
eight items, OTA selected items from the full set of the nine PHQ-9
items that maximized test information. Due to concerns about the use
of theninth itemof thePHQ (Corsonet al., 2004;Dubeet al., 2010; Lee,
Schulberg, Raue, & Kroenke, 2007; Razykov et al., 2013; Rief, Nanke,
Klaiberg, & Braehler, 2004), the same procedure was used to generate
eight additional short forms thatwere forced to exclude the ninth item.
In total, the OTA procedure yielded 16 candidate short forms.
For each of the 16 candidate short forms and the full-length form,
two scoring procedures were used to obtain estimates of each partic-
ipant's level of depressive symptomatology. First, the summed scores
across all items included in the short form were calculated. Second,
factor scores were estimated for each participant. Although summed
scores are typically relied upon for clinical use, the factor scores were
considered to provide a better estimate of the latent trait due to well-
known limitations of the summed score under theGPCM (Harel, 2014;
van der Ark, 2005).
2.6.3 Selection of final short form
The selection of the final short form was based on the following five
criteria: reliability, concurrent validity of summed scores, concurrent
validity of factor scores, and noninferior sensitivity and specificity,
because the elimination of items necessarily reduces information com-
pared to a full-length form.
Reliability of each candidate short form was assessed with Cron-
bach's alpha (Cronbach, 1951). The final selected form was required a
priori to have a Cronbach's alpha coefficient ≥0.80. Concurrent valid-
ity of the summed scores and factor scores was measured with the
Pearson's correlation coefficient between the full-length formand can-
didate short form scores, andwere required a priori to be≥0.90.
Diagnostic accuracy of each candidate short form was assessed
through a three-step process. First, the sensitivity and specificity of
each candidate short form for each of its possible cutoff summed score
values were estimated with a bivariate random-effects model. Second,
for each candidate short form, an optimal cutoff score was selected
using Youden's J statistic (Youden, 1950). For the full-length form, the
conventionally used cutoff score of 10was selected (Gilbody, Richards,
Brealey,&Hewitt, 2007;Kroenke&Spitzer, 2002;Kroenkeet al., 2001;
Spitzer, Kroenke,&Williams, 2000;Wittkampf,Naeije, Schene,Huyser,
& vanWeert, 2007). Third, twononinferiority testswere conducted for
each of the 16 candidate forms to compare sensitivity and specificity,
separately, to the full-length form. Noninferiority tests assess whether
the sensitivity or specificity of the short form is not lower than that
of the full-length form, up to a prespecified clinically significant tol-
erance (Counsell & Cribbie, 2015), such as 𝛿 = 0.05. To conduct the
noninferiority test, the sampling distribution of the test statistic was
generated through the bootstrap method (Liu, Ma, Wu, & Tai, 2006).
Bootstrapping resamples the original dataset, with replacement, to
generate new, artificial, datasets (Efron & Tibshirani, 1994). For each
noninferiority test, 2,000 bootstrap iterations were conducted, con-
trolling in each for the number of respondents with and without major
depression. For each bootstrap iteration, the bivariate random-effects
model was fit to each of the 16 candidate short forms and the full-
length form, and the sensitivities and specificities were computed
based on their cutoff scores. To account for the multiple testing in
the 32 total noninferiority tests, the Benjamini–Hochberg adjusted
P-value was used to determine the significance of the test at the 0.05
significance level (Benjamini &Hochberg, 1995).
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The factor analysis was conducted using Mplus 7 (Muthén &
Muthén, 2012). All other analyses were conducted using R version
3.3.3 (R Core Team, 2017). The GPCM was fit using the ltm pack-
age (Rizopoulos, 2006). The OTA analysis was conducted using the
lpSolveAPI package (Diao & van der Linden, 2011). The bivariate
random-effects model was fit using the lme4 package (Bates, Mächler,
Bolker, &Walker, 2015).
3 RESULTS
3.1 Search results and inclusion of primary data
Of 5,248 unique titles and abstracts identified from the database
search, 5,039 were excluded after title and abstract review and 113
after full-text review, leaving 96 eligible articles with data from 69
unique participant samples, of which 55 (80%) contributed datasets
(Supporting Information Figure 1). Authors of included studies con-
tributeddata from three unpublished studies, for a total of 58datasets.
Of these, we excluded 32 studies that administered the PHQ-9 in a
language other than English and six more that used the MINI. In total,
7,850 participants (863major depression cases) from20 primary stud-
ies were included. These studies were conducted in the United States,
New Zealand, Australia, Canada, the United Kingdom, and Cameroon.
The mean age of the sample was 33.9 years, and 55.3% of participants
were women. (See Table 1 for descriptive sample statistics, and Sup-
porting Information Table 1 for characteristics of each included study.)
3.2 Unidimensionality of PHQ-9
A single-factor model was fit to the PHQ-9 items with no specification
of residual correlations (𝜒2 [df = 36] = 1578.7, P < 0.0001,TLI =
0.966,CFI = 0.974,RMSEA = 0.086). Modification indices indi-
cated improvement of model fit if residuals of items that measure
physical symptoms (items 3, 4, and 5) were correlated. The model
was refitted with specification of three correlated residuals, and
fit improved (𝜒2 [df = 39] = 750.2, P < 0.0001,TLI = 0.982,CFI =
0.988,RMSEA = 0.062). Factor loadings for items were all moderately
high, with amedian of 0.763 and a range of 0.665–0.877.
3.3 Item response theorymodel and optimal test
assembly
Table 2 presents discrimination parameters for each item based on the
GPCM. The item with the greatest discrimination parameter was item
2. Other itemswith high values were items 1 and 6. Figure 1 shows the
information function of each of the nine items, as well as the total TIF.
Table 3 shows the items that were included in each of the 16 candi-
date short forms from the OTA analysis. For the candidate forms gen-
erated both with the inclusion of item 9 and without, items 3, 4, and
5 were only selected in the longest short forms, and quickly dropped
thereafter. Items 1, 2, and 6 were included in all forms of at least four
items. For the short forms generated from the full set of nine items,
item 9was included in all candidate short forms.
TABLE 1 Patient demographic and diagnostic characteristics
(N= 7,850)
Sociodemographic variables Summary
Age, years, mean [median]± SD (range) 52.0 [54]± 18.1 (18, 102)
Women, n (%) 4,335 (55.2)
PHQ-9 score, mean [median]± SD (range) 5.2 [3]± 5.4 (0, 27)
Country, n (%)
USA 2,781 (35.4)





Care setting, n (%)
Primary care 2,928 (37.3)
Nonmedical setting 1,389 (17.7)
Perinatal care 665 (8.5)
Neurology 607 (7.7)
HIV/AIDS care 398 (5.1)
Oncology 273 (3.5)
Medical rehabilitation 211 (2.7)
Rheumatology 201 (2.6)
Cardiology 100 (1.3)
Stroke care 72 (0.9)
Outpatients with coronary artery disease 1,006 (12.8)










3.4 Selection of final short form
Table 4 presents Cronbach's alpha values and concurrent validity cor-
relations for the 16 candidate short forms. Table 5 presents results of
the noninferiority tests for both sensitivity and specificity. There were
four short forms that satisfied our prespecified criteria in terms of
reliability, concurrent validity, and diagnostic accuracy. The four such
forms were: six-item and seven-item short forms that included item 9
and four-item and five-item short forms that excluded item 9.
The four-item short form was the shortest form that fulfilled all
criteria. The form includes: item 1 (“Little interest or pleasure in
doing things”), item 2 (“Feeling down, depressed, or hopeless”), item 6
(“Feeling bad about yourself—or that you are a failure or have let
yourself or your family down”), and item 8 (“Moving or speaking so
slowly that other people could havenoticed?Or theopposite—being so
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1 Little interest or pleasure in doing things 1.95
2 Feeling down, depressed, or hopeless 2.40
3 Trouble falling or staying asleep, or sleeping toomuch 0.93
4 Feeling tired or having little energy 1.37
5 Poor appetite or overeating 1.08
6 Feeling bad about yourself—or that you are a failure or have let yourself or your family down 1.90
7 Trouble concentrating on things, such as reading newspaper or watching television 1.41
8 Moving or speaking so slowly that other people could have noticed? Or the opposite—being so fidgety or restless
that you have beenmoving around a lot more than usual
1.29
9 Thoughts that youwould be better off dead or of hurting yourself in someway 1.77
F IGURE 1 The left hand plot shows the item information functions for each of the 9 items. The right hand plot shows the test information
function of the PHQ-9
fidgety or restless that you have been moving around a lot more than
usual”). The PHQ-Dep-4 maintained high reliability with a Cronbach's
alpha of 0.805 (95% CI, 0.795, 0.814) compared to 0.866 for the full-
length form. Correlations of the summed and factor scores between
the PHQ-Dep-4 and PHQ-9 were 0.919 (95% CI, 0.916, 0.923) and
0.910 (95% CI, 0.907, 0.914), respectively. The sensitivity and speci-
ficity of the PHQ-Dep-4 at its optimal cutoff of 4 were 0.788 (95% CI,
0.725, 0.840) and 0.837 (95%CI, 0.809, 0.861), respectively. Both sen-
sitivity and specificity were noninferior to the sensitivity (0.761; 95%
CI, 0.679, 0.787) and specificity (0.866; 95% CI, 0.836, 0.892) of the
full-length form.
4 DISCUSSION
This study illustrated how OTA methods can be used to effectively
shorten self-report symptom measures while maintaining compara-
ble diagnostic accuracy. OTA methods were applied to shorten the
nine-item PHQ-9 to a four-item version (PHQ-Dep-4). In addition to
maintaining similar sensitivity and specificity, the short form had min-
imal loss of information and maintained reliability and validity that
were comparable to the full-length form based on prespecified crite-
ria. Cronbach's alpha of the PHQ-Dep-4was 0.805, compared to 0.866
for the full form. Correlations of the summed score and factor score of
the PHQ-Dep-4 and PHQ-9were 0.919 and 0.910, respectively. As per
prespecified criteria, the sensitivity and specificity of the PHQ-Dep-4
(0.788 and 0.837, respectively) were within 5% of those of the PHQ-9
(0.761 and 0.866, respectively).
The four items included in the PHQ-Dep-4 included items 1, 2,
6, and 8 from the original PHQ-9. These items included the two
core depression items (depressed mood and loss of interest) that
make up the commonly used PHQ-2. According to diagnostic cri-
teria for major depression, at least one of these symptoms must
be present for a diagnosis. The other two items in the PHQ-Dep-
4 included an affective/cognitive item (feelings of failure) and a
somatic item (physical movement). Thus, the PHQ-Dep-4 includes
items that qualitatively represent the depressive symptomatology
construct well. We note that the PHQ-Dep-4 includes one somatic
symptom, whereas the full PHQ-9 includes four symptoms. One
study found that somatic symptoms may increase scores on the
PHQ-9 among somatically ill patients due to factors related to
somatic disease, but not depression, among scleroderma patients,
but the association was minimal (Leavens, Patten, Hudson, Baron,
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TABLE 3 Items included in optimal short forms of each length with item 9 included and item 9 excluded
Item number (X indicates inclusion)

















Item 9 eligible for inclusion in short forms
1 X
2 X X
3 X X X
4 X X X X
5 X X X X X
6 X X X X X X
7 X X X X X X X
8 X X X X X X X X
Item 9 ineligible for inclusion in short forms
1 X
2 X X
3 X X X
4 X X X X
5 X X X X X
6 X X X X X X
7 X X X X X X X
8 X X X X X X X X








Item 9 eligible for inclusion in short forms
1 NA 0.527 (0.511, 0.543) NA
2 0.533 (0.504, 0.563) 0.804 (0.796, 0.811) 0.800 (0.792, 0.808)
3 0.727 (0.712, 0.741) 0.863 (0.857, 0.868) 0.869 (0.863, 0.874)
4 0.801 (0.790, 0.810) 0.892 (0.887, 0.896) 0.895 (0.890, 0.899)
5 0.809 (0.799, 0.819) 0.920 (0.916, 0.923) 0.912 (0.909, 0.916)
6 0.835 (0.826, 0.843) 0.939 (0.937, 0.942) 0.931 (0.928, 0.934)
7 0.846 (0.839, 0.854) 0.971 (0.970, 0.973) 0.980 (0.979, 0.980)
8 0.858 (0.851, 0.865) 0.986 (0.986, 0.987) 0.989 (0.989, 0.990)
9 0.866 (0.860, 0.873) 1.000 (1.000, 1.000) 1.000 (1.000, 1.000)
Item 9 ineligible for inclusion in short forms
1 NA 0.781 (0.772, 0.79) NA
2 0.779 (0.763, 0.794) 0.849 (0.842, 0.855) 0.860 (0.855, 0.866)
3 0.816 (0.806, 0.826) 0.887 (0.882, 0.892) 0.891 (0.886, 0.895)
4 0.805 (0.795, 0.814) 0.919 (0.916, 0.923) 0.910 (0.907, 0.914)
5 0.832 (0.824, 0.840) 0.940 (0.936, 0.941) 0.930 (0.927, 0.933)
6 0.845 (0.838, 0.852) 0.970 (0.969, 0.971) 0.978 (0.977, 0.979)
7 0.857 (0.850, 0.863) 0.984 (0.984, 0.985) 0.988 (0.987, 0.988)
8 0.866 (0.860, 0.872) 0.997 (0.997, 0.997) 0.998 (0.998, 0.998)
Note:Bold values represent those of the final selected form.
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TABLE 5 Diagnostic accuracy results of the candidate short forms and their noninferiority test results
Form length Optimal cutoff Sensitivity (95%CI) P-value Specificity (95%CI) P-value
Item 9 eligible for inclusion in short forms
1 1 0.420 (0.369, 0.437) 0.976 0.943 (0.930, 0.954) 0.000
2 1 0.929 (0.900, 0.950) 0.000 0.650 (0.592, 0.685) 0.976
3 2 0.892 (0.843, 0.927) 0.000 0.717 (0.680, 0.751) 0.976
4 3 0.858 (0.810, 0.895) 0.000 0.776 (0.744, 0.805) 0.976
5 4 0.806 (0.749, 0.853) 0.000 0.826 (0.798, 0.851) 0.066
6 5 0.837 (0.808, 0.863) 0.000 0.837 (0.808, 0.863) 0.000
7 7 0.814 (0.715, 0.884) 0.000 0.849 (0.820, 0.873) 0.000
8 7 0.856 (0.855, 0.857) 0.000 0.802 (0.801, 0.804) 0.976
9 10 0.761 (0.679, 0.787) NA 0.866 (0.836, 0.892) NA
Item 9 ineligible for inclusion in short forms
1 1 0.916 (0.877, 0.944) 0.000 0.650 (0.599, 0.698) 0.976
2 2 0.880 (0.825, 0.919) 0.000 0.725 (0.688, 0.760) 0.976
3 3 0.844 (0.796, 0.882) 0.000 0.784 (0.752, 0.813) 0.976
4 4 0.788 (0.725, 0.840) 0.000 0.837 (0.809, 0.861) 0.000
5 5 0.792 (0.716, 0.873) 0.000 0.848 (0.820, 0.873) 0.000
6 6 0.855 (0.762, 0.916) 0.000 0.807 (0.773, 0.838) 0.976
7 7 0.844 (0.762, 0.902) 0.000 0.810 (0.776, 0.840) 0.976
8 8 0.871 (0.786, 0.925) 0.000 0.784 (0.746, 0.819) 0.976
Note:Bold values represent those of the final selected form.
& Thombs, 2012). Another study, of multiple sclerosis patients, did
not find that somatic symptoms influenced scores substantively
(Sjonnesen et al., 2012).
Both the actual PHQ-2 and the PHQ-8 were selected in the set of
16 candidate short forms. Neither of these, however, were selected by
the OTA procedure as optimal. The PHQ-Dep-4 has lower sensitivity
than thePHQ-2 (0.788 rather than0.880), but higher specificity (0.837
rather than 0.725). The PHQ-Dep-4, therefore, may represent a mid-
dle ground between shortening the full-length scale, while still retain-
ing desirablemeasurement and diagnostic properties. The PHQ-Dep-4
may be a useful option in some contexts because it is shorter than the
PHQ-9 and PHQ-8, but generates a wider score distribution than the
PHQ-2.
There are several limitations for this study thatmust be considered.
First, for the collection of data for the full IPDMA, it was not possible
to obtain primary data from 14 of the 69 eligible datasets. Second,
the full IPDMA excluded studies where the PHQ-9 was administered
exclusively to patients with known psychiatric conditions. Therefore,
the generalizability of the results should be confirmed when mon-
itoring treatment response. Third, the present study only included
participants for whom the PHQ-9was administered in English. Fourth,
a previous study showed that semistructured and fully structured
interviews have different characteristics as reference standards (B.
Levis et al., 2018). We excluded studies that used the MINI, given its
high rate of diagnosis relative to other diagnostic interviews (B. Levis
et al., 2018). We included studies that used both semistructured and
fully structured interviews as reference standards, and future work
should verify that our results apply in both cases. Although our dataset
included a specific sample of patients, we note that measurement
invariance or differential item functioning requirements have been
examined in previous studies of the PHQ-9 used as a continuous
measure across variables such as language (Arthurs, Steele, Hudson,
Baron, & Thombs, 2012; Merz, Malcarne, Roesch, Riley, & Sadler,
2013), culture (Baas et al., 2011; Hirsch, Donner-Banzhoff, & Bach-
mann, 2013; Huang, Chung, Kroenke, Delucchi, & Spitzer, 2006), and
medical diagnosis (Chung et al., 2015; Cook et al., 2011; Leavens
et al., 2012). These studies provide some degree of confidence that
the structure of the PHQ-9 is similar across groups. Lastly, there is
a need to replicate our results in different patient populations due
to unexamined heterogeneity across the studies included in this
analysis.
With regard to the OTA procedure, two limitations must be con-
sidered. First, the selection of a short version was sensitive to the
choice of criteria for the selection of the final form, and should be care-
fully considered in future analyses. Additionally, the OTA approach is
exploratory and data-driven, and the results of this study should be
replicated.
5 CONCLUSION
The study illustrates how patient self-report symptom measures can
be developed and validated using the OTA method, which uses pre-
specified objective criteria to determine the length and specific items
that should be included in a short form. The method was implemented
with a sample of 7,850 participants from 20 primary PHQ-9 diagnostic
studies. The four-item version was developed and validated based on
prespecified constraints on its test information, reliability, validity, and
diagnostic accuracy.
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